The observation that constitutive overexpression of the IFN/STAT1 pathway confers aggressive and therapy resistant tumor clones leaves several unanswered questions which need to be explored including the mechanisms by which activation of the IFN/STAT1 pathway switches the pathway from “cytotoxic” to “pro-survival” and the mechanisms that underlie this switch. The gene discussed is STAT1; the disease is neoplasm.